Exploration of the Components and Pharmacological Mechanisms of Keyin Pill-Induced Liver Injury Based on Network Pharmacology

Figure 2

H&E staining (scale: top row: 20X, 1000 μm; lower row: 200X, 100 μm) of liver tissue in each group. (a) control group, (b) model group, (c) low-dose of the KP group, (d) medium-dose of the KP group, and (e) high-dose of the KP group.

(a)

(b)

(c)

(d)

(e)